Novel sequences represent an new area in therapeutic development. Such short strings of amino residues present remarkable opportunities for targeting intractable targets involved in multiple diseases. Preliminary studies suggest that can deliver high interaction and show promising bioavailability features, paving ways to novel therapies. Continued